Question
Is fluvoxamine effective in preventing hospitalizations in high-risk adults with COVID-19?
Conclusion
In this study, compared with placebo, fluvoxamine decreased hospitalizations in high-risk symptomatic adults with COVID-19.
Recent Posts
- Fluvoxamine decreases hospitalizations in high-risk adults with COVID-19 (TOGETHER)
- Booster with Pfizer mRNA vaccine significantly reduces likelihood of infection and severe illness due to COVID-19 in adults 60+
- Evidence of benefit is lacking for low back pain relief with muscle relaxants
- Recurrent herpes zoster more common in women, younger adults, and the immunosuppressed
- There is limited data on ivermectin in patients with COVID-19